Drug Profile


Alternative Names: Alphanon

Latest Information Update: 22 Sep 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bentley Pharmaceuticals
  • Developer ALZA Corporation; Bentley Pharmaceuticals
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Haemorrhoids

Most Recent Events

  • 22 Sep 2000 Discontinued-I for Haemorrhoids in USA (Transdermal)
  • 14 May 1998 Phase-I clinical trials for Haemorrhoids in USA (Transdermal)
  • 15 Feb 1996 Belmac is now known as Bentley Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top